Elena R Chernykh Selected Research

DNA Probes

1/2019	Identification of the xenograft and its ascendant sphere-forming cell line as belonging to EBV-induced lymphoma, and characterization of the status of sphere-forming cells.
1/2018	Novel Cancer Stem Marker and Its Applicability for Grading Primary Human Gliomas.
2/2017	Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena R Chernykh Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 08/2009
6	Multiple Myeloma 11/2021 - 10/2015
5	Ascites 01/2020 - 10/2014
3	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2012
2	Glioma (Gliomas) 07/2021 - 07/2013
2	Tuberculosis (Tuberculoses) 01/2015 - 01/2012
1	Vascular Remodeling 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020
1	Hodgkin Disease (Hodgkin's Disease) 10/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2017
1	Myopia 01/2017
1	Choroidal Neovascularization 01/2017
1	Stroke (Strokes) 01/2016
1	Retinal Vein Occlusion 12/2015
1	Lymphoma (Lymphomas) 10/2015
1	Pathologic Processes 10/2015
1	Spontaneous Abortion (Miscarriage) 01/2015
1	Necrosis 01/2015
1	Adenocarcinoma 01/2015
1	Cerebral Palsy (Spastic Diplegia) 01/2014
1	Pulmonary Tuberculosis 01/2012
1	Body Weight (Weight, Body) 08/2009
1	Proteinuria 05/2007
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2007

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2007
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 08/2009
3	Cytostatic AgentsIBA 01/2022 - 11/2010
3	Biological ProductsIBA 11/2021 - 02/2017
3	DNA ProbesIBA 01/2019 - 02/2017
3	CytokinesIBA 01/2017 - 12/2015
2	Ranibizumab (Lucentis)FDA Link 01/2017 - 12/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 12/2015
2	AntigensIBA 01/2015 - 01/2012
2	Tuberculin (PPD)IBA 01/2015 - 01/2012
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	EpitopesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 02/2017
1	Interleukin-13IBA 01/2017
1	Chemokine CCL5IBA 01/2017
1	RhodaminesIBA 10/2016
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	TabletsIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	Dehydroepiandrosterone SulfateIBA 01/2015
1	VaccinesIBA 01/2015
1	Cancer VaccinesIBA 07/2013
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2013
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2010
1	Adenosine Triphosphate (ATP)IBA 05/2007
1	Antinuclear AntibodiesIBA 05/2007
1	Deoxyribonucleases (DNase)FDA Link 05/2007
1	Immunoglobulin G (IgG)IBA 05/2007
1	Adenosine Triphosphatases (ATPase)IBA 05/2007
1	Polysaccharides (Glycans)IBA 05/2007
1	Amylases FDA Link 05/2007

Therapy/Procedure

11	Therapeutics 01/2022 - 08/2009
6	Drug Therapy (Chemotherapy) 11/2021 - 01/2016
5	Hematopoietic Stem Cell Transplantation 11/2021 - 10/2015
3	Transplantation 07/2021 - 10/2015
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018 - 01/2016
2	Injections 03/2016 - 11/2010
1	Palliative Care (Palliative Therapy) 01/2022
1	Immunotherapy 11/2021
1	Cell Transplantation 01/2016
1	Subcutaneous Injections 08/2009